Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study

被引：0
|
作者：
Li-Nong Ji
Chang-Yu Pan
Ju-Ming Lu
Hong Li
Qiang Li
Qi-Fu Li
Yong-De Peng
Hao-Ming Tian
Chen Yao
Zhi-Gang Zhao
Ru-Ya Zhang
Xiang-Ling Wang
Lei Wang
机构：
[1] Peking University People’s Hospital,
[2] 11 Xizhimen Nan Dajie,undefined
[3] Chinese PLA General Hospital,undefined
[4] Sir Run Run Shaw Hospital,undefined
[5] Zhejiang University Medical College,undefined
[6] The 2nd Affiliated Hospital of Harbin Medical University,undefined
[7] The First Affiliated Hospital of Chongqing Medical University,undefined
[8] Shanghai First People's Hospital,undefined
[9] West China Hospital,undefined
[10] Sichuan University,undefined
[11] Peking University First Hospital,undefined
[12] Henan Provincial People's Hospital,undefined
[13] Beijing Novartis Pharma Co. Ltd,undefined
来源：
Cardiovascular Diabetology | / 12卷
关键词：
VISION study; Vildagliptin; Type 2 diabetes; Study design; DPP-IV inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes
    He, Yan-Ling
    Sabo, Ron
    Picard, Franck
    Wang, Yibin
    Herron, Jerry
    Ligueros-Saylan, Monica
    Dole, William P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1265 - 1272
  • [32] Efficacy and safety of linagliptine in combination with metformin in patients with type 2 diabetes uncontrolled on metformin monotherapy
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Tocque-le Goussee, E.
    Woerle, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A107 - A108
  • [33] Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study
    Gautam, Kumar
    Tripathy, Ratikanta
    Meher, Dayanidhi
    Sahoo, Jyoti Prakash
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [34] Vildagliptin efficacy and safety in patients with type 2 diabetes inadequately controlled on dual metformin plus sulfonylurea therapy
    Lukashevich, V.
    Wang, M.
    Del Prato, S.
    Araga, M.
    Kothny, W.
    DIABETOLOGIA, 2012, 55 : S353 - S353
  • [35] Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
    Williams-Herman, Debora
    Johnson, Jeremy
    Teng, Rujun
    Luo, Edmund
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Amatruda, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 569 - 583
  • [36] Evaluation of Efficacy and Tolerability of Gliclazide and Metformin Combination: A Multicentric Study in Patients With Type 2 Diabetes Mellitus Uncontrolled on Monotherapy With Sulfonylurea or Metformin
    Pareek, Anil
    Chandurkar, Nitin
    Zawar, Shyamsundar
    Agrawal, Navneet
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) : 559 - 565
  • [37] Comparison of the Efficacy and Safety of Metformin-Based Combination Therapy Versus Metformin Alone in Children and Adolescents With Type 2 Diabetes Mellitus: A Meta-Analysis
    Khan, Raza A.
    Patel, Nidhi
    Folajimi, Atunde
    Bai, Bansari Raveena
    Patel, Vrushak
    Komminni, Praveen Kumar
    Palleti, Sujith K.
    Hirani, Shamsha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [38] Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Strozik, Agnieszka
    Steposz, Arkadiusz
    Basiak, Marcin
    Drozdz, Magdalena
    Okopien, Boguslaw
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 24 - 31
  • [39] Multifactorial Effects of Vildagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Mellitus
    Strozik, Agnieszka
    Steposz, Arkadiusz
    Okopien, Boguslaw
    DIABETES, 2013, 62 : A668 - A668
  • [40] Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
    Israel, Marc K.
    Istvan, Eva
    Baron, Michelle A.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1167 - 1178
12345